Quick Answer
EASTMAN CHEMICAL CO reported Total Revenue of $8.75 billion for fiscal year 2025.
EASTMAN CHEMICAL CO — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | $8.75B -6.7% |
$9.38B +1.9% |
$9.21B -12.9% |
$10.58B +1.0% |
$10.48B +23.6% |
$8.47B -8.6% |
| Net Income | $474.00M -47.6% |
$905.00M +1.2% |
$894.00M +12.7% |
$793.00M -7.5% |
$857.00M +79.3% |
$478.00M -37.0% |
| Diluted EPS | $4.10 -46.5% |
$7.67 +2.4% |
$7.49 +18.0% |
$6.35 +1.6% |
$6.25 +78.6% |
$3.50 -36.1% |
| Total Assets | $14.86B -2.3% |
$15.21B +4.0% |
$14.63B -0.2% |
$14.67B -5.5% |
$15.52B -3.5% |
$16.08B +0.5% |
| Cash and Equivalents | $566.00M -32.4% |
$837.00M +52.7% |
$548.00M +11.2% |
$493.00M +7.4% |
$459.00M -18.6% |
$564.00M +176.5% |
| Long-Term Debt | $4.20B -8.0% |
$4.57B +6.1% |
$4.30B +7.0% |
$4.03B -8.8% |
$4.41B -16.3% |
$5.27B -6.1% |
| Stockholders Equity | $5.96B +3.1% |
$5.78B +5.9% |
$5.46B +5.9% |
$5.15B -9.7% |
$5.70B -5.3% |
$6.02B +1.1% |
| R&D Expense | $255.00M +2.0% |
$250.00M +4.6% |
$239.00M -9.5% |
$264.00M +3.9% |
$254.00M +12.4% |
$226.00M -3.4% |
| Operating Income | — | — | — | — | — | — |
| Gross Profit | $1.84B -19.5% |
$2.29B +11.1% |
$2.06B -3.6% |
$2.14B -14.5% |
$2.50B +26.6% |
$1.98B -11.6% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | September 30, 2025 | $2.20B | -10.6% | -3.7% |
| Net Income | September 30, 2025 | $47.00M | -73.9% | -66.4% |
| Diluted EPS | September 30, 2025 | $0.40 | -73.9% | -66.7% |
| Total Assets | September 30, 2025 | $14.98B | -0.5% | -1.6% |
| Cash and Equivalents | March 31, 2022 | $487.00M | -9.8% | +6.1% |
| Long-Term Debt | September 30, 2025 | $4.79B | +3.9% | +0.1% |
| Stockholders Equity | September 30, 2025 | $5.77B | +2.1% | -1.1% |
| R&D Expense | September 30, 2025 | $63.00M | -3.1% | -6.0% |
| Operating Income | September 30, 2017 | $460.00M | +29.2% | +9.5% |
| Gross Profit | September 30, 2025 | $433.00M | -28.4% | -14.4% |
- EASTMAN CHEMICAL CO reported Total Revenue of $8.75 billion for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -6.7% in Total Revenue compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Net Income of $474.00 million for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -47.6% in Net Income compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Diluted EPS of $4.10 per share for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -46.5% in Diluted EPS compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Total Assets of $14.86 billion for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -2.3% in Total Assets compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Cash and Equivalents of $566.00 million for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -32.4% in Cash and Equivalents compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Long-Term Debt of $4.20 billion for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -8.0% in Long-Term Debt compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Stockholders Equity of $5.96 billion for fiscal year 2025.
- EASTMAN CHEMICAL CO showed an increase of +3.1% in Stockholders Equity compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported R&D Expense of $255.00 million for fiscal year 2025.
- EASTMAN CHEMICAL CO showed an increase of +2.0% in R&D Expense compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Operating Income of $1.53 billion for fiscal year 2017.
- EASTMAN CHEMICAL CO showed an increase of +10.8% in Operating Income compared to the prior fiscal year.
- EASTMAN CHEMICAL CO reported Gross Profit of $1.84 billion for fiscal year 2025.
- EASTMAN CHEMICAL CO showed a decrease of -19.5% in Gross Profit compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: